Avsar.

Healthcare · Pharmaceuticals

J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM)

₹2,408.90

Mkt cap
₹38,677 Cr
P/E ratio
53.80
P/B
9.30
Div yield
0.91%
ROE
18.90%
ROCE
25.40%
EPS (TTM)
₹44.78
Book value
₹259
52W range
1,609–2,506
Sector
Healthcare

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally. [1]

NSE JBCHEPHARMBSE 506943jbpharma.com
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthModerate
TechnicalsBullish
52-week range
−3.87% from high
₹2,409
₹1,609+49.75% from low₹2,506
Current
₹2,408.90
Prev close
₹2,416.10
Day
−0.30%
Price performance
1D
−0.30%
1W
−1.09%
1M
+9.71%
3M
+21.97%
6M
+27.55%
1Y
+47.55%
YTD
+30.18%

Financials

F
Revenue, profit & margin
P/E ratio
53.8×
JBCHEPHARM is 58% above the sector median of 34.0×
JBCHEPHARM53.8×
Sector median34.0×
 Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Trend
Sales7628968828458621,0041,0019639491,0941,0851,065904
Expenses599664638621664724730709723793775769703
Operating Profit164232244223198280271255226301310296201
OPM %21%26%28%26%23%28%27%26%24%28%29%28%22%
Other Income568717610814151518-15
Interest14121012962311121
Depreciation32313234414142424643444550
Profit before tax122194209184165240237218193272279267135
Tax %28%27%28%27%23%26%26%25%25%25%26%26%25%
Net Profit88142151134126177175162146202208198101
EPS in Rs5.669.199.728.628.1311.3911.2410.459.3612.9613.2712.636.31
Raw PDF

Earnings

EResults dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +0.38% · closed higher next day 27 of last 61
 Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26†
Broadcast10 Aug '238 Nov '237 Feb '2418 May '248 Aug '24◦6 Nov '24◦5 Feb '2514 May '25◦30 Jul '25◦11 Nov '25◦16 Jan '26◦13 Jul '26◦
Earnings day−0.01%+0.65%+4.33%+0.99%−0.88%−1.11%−1.63%+1.63%−0.75%−0.49%+1.19%+1.12%
+1 day−1.15%+3.48%+2.32%−2.82%−0.11%−2.13%−1.48%+2.14%−2.50%−0.54%−1.03%+1.87%
+5 days−1.59%+3.43%−2.85%−2.35%−0.18%−10.57%−6.66%+4.47%−5.23%−4.18%−1.39%—
+15 days+3.14%+0.53%−7.25%+3.08%+1.18%−6.47%−9.43%+5.38%−1.95%−3.55%+1.00%—
+30 days+5.71%+11.43%−6.15%−1.98%+0.23%−1.12%−5.27%+8.66%−5.79%−0.71%+7.76%—
FilingXBRLXBRLXBRLXBRLXBRLXBRLXBRLPDFPDFPDFXBRLXBRL

Corporate actions

CLast 6 months
KindValueEx-dateRecord
dividend
Dividend - Rs 9.30 Per Share
9.3029 May '2629 May '26
dividend
Interim Dividend - Rs 12.70 Per Share
12.7011 Feb '2611 Feb '26

Shareholding

Sas of Mar 2026
48.80%Promoter
Promoters48.80%1.25
FIIs16.33%1.45
DIIs21.38%1.97
Public13.48%0.73
Government0.00%
Ownership trend

Peers

P8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,941.1037.484,65,7350.82%2,710+13.58%14,612+12.76%20.53%
Divi's Lab.₹7,248.5073.361,92,4250.41%751+13.44%2,831+9.52%21.97%
Torrent Pharma.₹4,961.5086.111,88,7200.77%364−20.58%4,197+41.84%15.19%
Cipla₹1,410.6031.841,13,9550.92%786−39.19%7,119+2.33%15.49%
Zydus Lifesci.₹1,108.7020.381,10,5930.09%1,341+21.92%7,587+16.22%21.14%
Lupin₹2,370.5019.061,08,3870.76%1,469+101.49%7,475+31.89%29.93%
Mankind Pharma₹2,507.2051.441,03,5460.04%559+34.23%3,443+11.81%13.53%
J B Chemicals &₹2,408.9053.8338,6770.91%101−16.99%904−4.77%25.45%
Median: 157 Co.₹432.0534.031,9780.10%15+28.10%176+17.66%15.10%

Filings

D
Annual reports15
Financial Year 2026bseFinancial Year 2025bseFinancial Year 2024bseFinancial Year 2023bseFinancial Year 2022bseFinancial Year 2021bseFinancial Year 2020bseFinancial Year 2019bseFinancial Year 2018bseFinancial Year 2017bseFinancial Year 2016bseFinancial Year 2015bseFinancial Year 2014bseFinancial Year 2013bseFinancial Year 2012bse
Concall transcripts56
TranscriptMay 2026RECMay 2026TranscriptJan 2026PPTJan 2026RECJan 2026TranscriptNov 2025PPTNov 2025TranscriptAug 2025PPTAug 2025PPTJun 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024TranscriptMay 2024PPTMay 2024TranscriptFeb 2024PPTFeb 2024RECFeb 2024TranscriptDec 2023
Credit ratings6
Rating update 17 MarcrisilRating update 31 Dec 2025crisilRating update 3 Oct 2025crisilRating update 8 Jul 2025crisilRating update 28 Mar 2025crisilRating update 29 Dec 2023crisil
Announcements5
Intimation Of Effective Date Of Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders 8 Jul - JB Chemicals merged into Torrent Pharma effective 8 July 2026; appointed date 21 January 2026.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 JulRecord Date For The Purpose Of Determining The Shareholders Of The Company Who Shall Be Entitled To Receive Fully Paid-Up Equity Shares Of Torrent Pharma As Per The Share Exchange Ratio 7 Jul - Record date fixed for 17 July 2026 under JB Chemicals-Torrent Pharma amalgamation, ratio 51:100.Receipt Of Certified Copy Of Order Passed By National Company Law Tribunal, Ahmedabad Bench ('NCLT') Regarding The Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders. 7 Jul - Certified copy received for NCLT order sanctioning JB Chemicals amalgamation with Torrent Pharmaceuticals on 6 July 2026.Pronouncement Of Final Order By The Hon'Ble National Company Law Tribunal, Ahmedabad Bench Sanctioning The Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders 6 Jul - NCLT sanctioned J.B. Chemicals’ amalgamation with Torrent Pharmaceuticals on July 6, 2026.